GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CytomX Therapeutics Inc (STU:6C1) » Definitions » E10

CytomX Therapeutics (STU:6C1) E10 : €-1.60 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is CytomX Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CytomX Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.156. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.60 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-12), CytomX Therapeutics's current stock price is €1.386. CytomX Therapeutics's E10 for the quarter that ended in Mar. 2024 was €-1.60. CytomX Therapeutics's Shiller PE Ratio of today is .


CytomX Therapeutics E10 Historical Data

The historical data trend for CytomX Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytomX Therapeutics E10 Chart

CytomX Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -1.55

CytomX Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -1.55 -1.60

Competitive Comparison of CytomX Therapeutics's E10

For the Biotechnology subindustry, CytomX Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CytomX Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CytomX Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CytomX Therapeutics's Shiller PE Ratio falls into.



CytomX Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CytomX Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.156/131.7762*131.7762
=0.156

Current CPI (Mar. 2024) = 131.7762.

CytomX Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201406 0.000 100.560 0.000
201409 -0.106 100.428 -0.139
201412 -0.139 99.070 -0.185
201503 -0.202 99.621 -0.267
201506 -0.193 100.684 -0.253
201509 -0.378 100.392 -0.496
201512 -0.307 99.792 -0.405
201603 -0.395 100.470 -0.518
201606 -0.347 101.688 -0.450
201609 -0.356 101.861 -0.461
201612 -0.370 101.863 -0.479
201703 -0.215 102.862 -0.275
201706 -0.614 103.349 -0.783
201709 -0.235 104.136 -0.297
201712 0.025 104.011 0.032
201803 -0.324 105.290 -0.406
201806 -0.300 106.317 -0.372
201809 -0.454 106.507 -0.562
201812 -0.650 105.998 -0.808
201903 -0.274 107.251 -0.337
201906 -0.566 108.070 -0.690
201909 -0.472 108.329 -0.574
201912 -1.314 108.420 -1.597
202003 0.235 108.902 0.284
202006 -0.302 108.767 -0.366
202009 -0.272 109.815 -0.326
202012 -0.822 109.897 -0.986
202103 -0.218 111.754 -0.257
202106 -0.249 114.631 -0.286
202109 -0.298 115.734 -0.339
202112 -0.805 117.630 -0.902
202203 -0.445 121.301 -0.483
202206 -0.426 125.017 -0.449
202209 -0.444 125.227 -0.467
202212 -0.123 125.222 -0.129
202303 -0.047 127.348 -0.049
202306 -0.018 128.729 -0.018
202309 0.037 129.860 0.038
202312 0.009 129.419 0.009
202403 0.156 131.776 0.156

Add all the adjusted EPS together and divide 10 will get our e10.


CytomX Therapeutics  (STU:6C1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


CytomX Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of CytomX Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


CytomX Therapeutics (STU:6C1) Business Description

Traded in Other Exchanges
Address
151 Oyster Point Boulevard, Suite 400, South San Francisco, CA, USA, 94080
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

CytomX Therapeutics (STU:6C1) Headlines

No Headlines